Role of the RNA-binding protein family in gynecologic cancers

Related Experiment Video

Updated: Jul 16, 2025

Isolation of Cognate RNA-protein Complexes from Cells Using Oligonucleotide-directed Elution
10:53

Isolation of Cognate RNA-protein Complexes from Cells Using Oligonucleotide-directed Elution

Published on: January 16, 2017

9.1K

Linlin Hao1, Jian Zhang2, Zhongshan Liu1

  • 1Department of Tumor Radiotherapy, The Second Hospital of Jilin University Changchun 130041, Jilin, China.

American Journal of Cancer Research
|September 11, 2023
PubMed

Insights

RNA-binding proteins (RBPs) are crucial in gynecological cancers. Understanding their role in cancer progression offers new diagnostic and therapeutic strategies for advanced or recurrent gynecological malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gynecological cancers present a significant health challenge, with poor prognoses for advanced, metastatic, or recurrent cases.
  • RNA-binding proteins (RBPs) regulate critical post-transcriptional processes, including alternative splicing, mRNA stability, and translation.
  • Aberrant RBP expression is linked to oncogene and tumor suppressor gene dysfunction, driving cancer development and progression.

Purpose of the Study:

  • To review the multifaceted roles of RBPs in the development and progression of gynecological malignancies.
  • To explore the potential of RBPs as diagnostic biomarkers and therapeutic targets in gynecological cancers.

Main Methods:

  • Literature review and synthesis of existing research on RBPs in gynecological cancers.
  • Analysis of RBP involvement in key cellular processes relevant to cancer biology.

Main Results:

  • RBPs are implicated in the pathogenesis of various gynecological cancers.
  • Dysregulation of specific RBPs contributes to cancer cell proliferation, migration, and treatment resistance.
  • RBPs influence crucial post-transcriptional events that govern gene expression in gynecological malignancies.

Conclusions:

  • RBPs are pivotal players in gynecological carcinogenesis and progression.
  • Targeting RBPs presents a promising avenue for novel diagnostic and therapeutic strategies in gynecological oncology.
  • Further research into RBP functions can guide the development of effective treatments for advanced gynecological cancers.
Keywords:
Gynecological cancerRNA-binding proteincervical cancerendometrial cancerovarian cancer

More Related Videos

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells11:11

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

8.1K
Novel RNA-Binding Proteins Isolation by the RaPID Methodology11:19

Novel RNA-Binding Proteins Isolation by the RaPID Methodology

Published on: September 30, 2016

9.0K

Related Concept Videos

Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.9K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.2K